Jeffrey Yordon

Jeffrey Yordon has diverse work experience in various leadership roles. Jeffrey currently serves as the Chief Executive Officer of Avenacy. Prior to this, they held the position of Chairman of the Board at the Northern Illinois University Foundation Board, where they focused on developing and supporting a culture of giving within the NIU community. Yordon also served as a Board Member and Vice Chairman/Secretary at the Illinois Sports Facility Authority, overseeing the operation and maintenance of sports facilities. In addition, they worked as the President and Chief Operating Officer of Athenex Pharma, a commercial company of Athenex Pharmaceuticals, where they drove the company's growth through acquisitions, partnerships, and product development agreements. Previously, Yordon founded Sagent Pharmaceuticals and served as its Chairman and CEO before relinquishing their role in 2014.

Jeffrey Yordon attended Northern Illinois University from 1966 to 1970, earning a Bachelor's degree in Political Science and Marketing.